Gene description for IFITM1 |
Gene name |
interferon induced transmembrane protein 1 |
Gene symbol |
IFITM1 |
Other names/aliases |
9-27 CD225 DSPA2a IFI17 LEU13 |
Species |
Homo sapiens |
Experiment description of studies that identified IFITM1 in Ascites |
1
|
Experiment ID | 158 |
Identified molecule | protein
|
Extracellular vesicle type | Microvesicles |
MISEV | EVs |
Identification method | Mass spectrometry [LTQ]
|
PubMed ID |
21630462
|
Organism | Homo sapiens |
Experiment description | Proteomic analysis of microvesicles derived from human colorectal cancer ascites |
Authors | Choi DS, Park JO, Jang SC, Yoon YJ, Jung JW, Choi DY, Kim JW, Kang JS, Park J, Hwang D, Lee KH, Park SH, Kim YK, Desiderio DM, Kim KP, Gho YS |
Journal name |
Proteomics
|
Publication year | 2011 |
Sample | Ascites |
Sample name | Malignant ascites - Colorectal cancer patient 2 |
Isolation/purification methods | Differential centrifugation Sucrose density gradient OptiPrep density gradient |
Flotation density | 1.09 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry [LTQ] |
EV-TRACK |
EV110017: EV-METRIC:38%
|
|
|
2
|
Experiment ID | 159 |
Identified molecule | protein
|
Extracellular vesicle type | Microvesicles |
MISEV | EVs |
Identification method | Mass spectrometry [LTQ]
|
PubMed ID |
21630462
|
Organism | Homo sapiens |
Experiment description | Proteomic analysis of microvesicles derived from human colorectal cancer ascites |
Authors | Choi DS, Park JO, Jang SC, Yoon YJ, Jung JW, Choi DY, Kim JW, Kang JS, Park J, Hwang D, Lee KH, Park SH, Kim YK, Desiderio DM, Kim KP, Gho YS |
Journal name |
Proteomics
|
Publication year | 2011 |
Sample | Ascites |
Sample name | Malignant ascites - Colorectal cancer patient 3 |
Isolation/purification methods | Differential centrifugation Sucrose density gradient OptiPrep density gradient |
Flotation density | 1.09 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry [LTQ] |
EV-TRACK |
EV110017: EV-METRIC:38%
|
|
|